Donna H. Ryan, MD

 2013 George A. Bray Founders Award

Donna-Ryan04 copy

Donna H. Ryan, MD, is Professor Emeritus at Pennington Biomedical Research Center in Baton Rouge Louisiana. She served as Associate Executive Director at Pennington Biomedical for 34 years where she was active in research, teaching and administration. Her research accomplishments include landmark studies of omega 3 fatty acids, and membership on the teams that developed the NIH-sponsored feeding studies, DELTA (Dietary Effects on Lipoproteins and Thrombosis in Atherosclerosis) and DASH (Dietary Approaches to Stop Hypertension).

Dr. Ryan was an Investigator on NIH multicenter lifestyle intervention studies DPP (Diabetes Prevention Program) and POUNDS Lost and the Look AHEAD study. Dr. Ryan worked with the Louisiana Office of Group Benefits to conduct LOSS (Louisiana Obese Subjects Study), a pragmatic clinical trial of intensive medical therapy for severe obesity conducted in six Louisiana primary care clinics. This work continues in a translational phase as HEADS UP!.Dr. Ryan was PI of a Military Nutrition Grant from 1988-2011 to develop improvements to soldier readiness, nutrition and health.

Dr. Ryan serves as co-Chair the panel to revise the NIH-supported evidence-based Guidelines on the Evaluation and Management of Overweight and Obesity in Adults. She is past President of The Obesity Society and currently Associate Editor in Chief of the journal, Obesity. Her scholarly activities include authorship of more than 170 original publications and 45 books, chapters and reviews, primarily in the field of obesity. Dr. Ryan has served the scientific community as a reviewer and advisor in many capacities including the following: NSF Medical R&D Expenditures Workshop 2006; National Dairy Council Review Team for Children's Hospital Oakland Research Institute, 2006; Chair, Data Safety Monitoring Board (DSMB), NIH Grant, "Safety and Efficacy of Low and High Carbohydrate Diets,” 2002-2008, Member DSMB for EARLY Studies 2010- present and reviewer for European Union Innovative Medicines Initiative, 2011-12. Dr. Ryan has served as a scientific advisor and/or consultant to Abbott, Knoll, Procter and Gamble, Novartis, TAP Pharmaceuticals, Slim Fast, Solvay, Weight Watchers, Alere Wellbeing, Nutrisystem, Vivus, Arena, Sanofi-Aventis, Ajinomoto, Merck, Takeda, Vivus, Eisai, Arena, Novo-Nordisk and Scientific Intake.

Find out about the TOS Awards and the other 2013 recipients here.

(Please note: External Links are provided as a courtesy. The Obesity Society is not responsible for the content on sites accessed through external links.)

clinician directory

SECTIONS

obesity links

OW web logo

OW On Demand